These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9772305)

  • 61. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
    Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
    Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
    Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
    Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Electrogene therapy with p53 of murine sarcomas alone or combined with electrochemotherapy using cisplatin.
    Grosel A; Sersa G; Kranjc S; Cemazar M
    DNA Cell Biol; 2006 Dec; 25(12):674-83. PubMed ID: 17233116
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo.
    Hamilton NH; Mahalingam S; Banyer JL; Ramshaw IA; Thomson SA
    Scand J Immunol; 2004 Mar; 59(3):246-54. PubMed ID: 15030574
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
    Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
    J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer.
    Rieger J; Ständer M; Löschmann PA; Heneka M; Dichgans J; Klockgether T; Weller M
    Oncogene; 1998 Nov; 17(18):2323-32. PubMed ID: 9811463
    [TBL] [Abstract][Full Text] [Related]  

  • 69. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
    Papadopoulou MV; Bloomer WD; Hollingshead MG
    Anticancer Res; 2005; 25(3B):1865-9. PubMed ID: 16158918
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of viral carcinogenesis by Phyllanthus amarus.
    Harikumar KB; Kuttan G; Kuttan R
    Integr Cancer Ther; 2009 Sep; 8(3):254-60. PubMed ID: 19815595
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The combination of recombinant rAd-p53 and adriamycin for management of primary drug resistance in chemotherapy of lung squamous cell cancer].
    Du CH; Wu Z; Xu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):622-4. PubMed ID: 17129471
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412.
    Zaugg K; Rocha S; Resch H; Hegyi I; Oehler C; Glanzmann C; Fabbro D; Bodis S; Pruschy M
    Cancer Res; 2001 Jan; 61(2):732-8. PubMed ID: 11212276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Interferon-modification of the in vitro radiation response of cultured human KNS-42 cells].
    Korosue K; Tamaki N; Matsumoto S; Takeshita I; Fukui M
    Neurol Med Chir (Tokyo); 1984 Apr; 24(4):233-9. PubMed ID: 6205307
    [No Abstract]   [Full Text] [Related]  

  • 74. Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy.
    Qi Z; Long X; Liu J; Cheng P
    Front Cell Neurosci; 2022; 16():819363. PubMed ID: 36159398
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.
    Wollmann G; Ozduman K; van den Pol AN
    Cancer J; 2012; 18(1):69-81. PubMed ID: 22290260
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oncolytic viral therapy of malignant glioma.
    Parker JN; Bauer DF; Cody JJ; Markert JM
    Neurotherapeutics; 2009 Jul; 6(3):558-69. PubMed ID: 19560745
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adenoviral virotherapy for malignant brain tumors.
    Nandi S; Lesniak MS
    Expert Opin Biol Ther; 2009 Jun; 9(6):737-47. PubMed ID: 19456208
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advances in oncolytic virus therapy for glioma.
    Haseley A; Alvarez-Breckenridge C; Chaudhury AR; Kaur B
    Recent Pat CNS Drug Discov; 2009 Jan; 4(1):1-13. PubMed ID: 19149710
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gene therapy trials for the treatment of high-grade gliomas.
    Sonabend AM; Ulasov IV; Lesniak MS
    Gene Ther Mol Biol; 2007; 11(A):79-92. PubMed ID: 17625614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas.
    Shah AC; Benos D; Gillespie GY; Markert JM
    J Neurooncol; 2003 Dec; 65(3):203-26. PubMed ID: 14682372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.